FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5th–6 th2011”

Journal of Translational Medicine

Meeting Report

David F Stroncek¹  Axel Hauschild²  F Stephen Hodi³  Donald L Morton⁴  Mark B Faries⁴  Antonio M Grimaldi⁵  Nicola Mozzillo⁵  Paolo A Ascierto⁶  Jeffrey E Gershenwald⁷  John M Kirkwood⁸  Brendan Curti⁹  Helen Gogas^1,10  Sancy Leachmann^1,11  Kenneth Grossmann^1,11  Rodney Stewart^1,11  Franco M Marincola^1,12  Ena Wang^1,12  Bernard A Fox^1,13  Keith Flaherty^1,14  Michele Maio^1,15  Richard Marais^1,16  Antoni Ribas^1,17  Giuseppe Palmieri^1,18  Thomas F Gajewski^1,19  Soldano Ferrone^2,20  Richard Kefford^2,21 

[1] Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA;Department of Dermatology, University of Kiel, Kiel, Germany;Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;Department of Melanoma Research, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA, USA;Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy;Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy;Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”, Via Mariano Semmola, 80131, Naples, Italy;Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Division of Hematology/Oncology, Departments of Medicine, Dermatology, and Translational Science, University of Pittsburgh School of Medicine and Melanoma Program of the Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA;First Department of Medicine, Athens Medical School, University of Athens, Athens, Greece;Huntsman Cancer Institute, University of Utah, Melanoma and Cutaneous Oncology Program, Salt Lake City, UT, USA;Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Center for Human Immunology (CHI), NIH, Bethesda, MD, USA;Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, and Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA;Massachusetts General Hospital Cancer Center, Boston, MA, USA;Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;Molecular Oncology Group, The Paterson Institute for Cancer Research, Wilmslow Road, M20 4BX, Manchester, UK;UCLA Medical Center, Factor Bldg., 10833 Le Conte Ave., 11-934, Los Angeles, CA, USA;Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council (CNR), Sassari, Italy;University of Chicago, Chicago, IL, USA;University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA;Westmead Institute for Cancer Research, Westmead Millennium Institute and Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia;

关键词: Melanoma;    Overall Survival;    Sentinel Lymph Node;    Metastatic Melanoma;    Ipilimumab;   

DOI  :  10.1186/1479-5876-10-83

 received in 2012-04-26, accepted in 2012-05-02,  发布年份 2012

来源: Springer

【 摘 要 】

After more than 30 years, landmark progress has been made in the treatment of cancer, and melanoma in particular, with the success of new molecules such as ipilimumab, vemurafenib and active specific immunization.After the first congress in December 2010, the second edition of “Melanoma Research: a bridge from Naples to the World” meeting, organized by Paolo A. Ascierto (INT, Naples, Italy), Francesco M. Marincola (NIH, Bethesda, USA), and Nicola Mozzillo (INT, Naples, Italy) took place in Naples, on 5–6 December 2011. We have identified four new topics of discussion: Innovative Approaches in Prevention, Diagnosis and Surgical Treatment, New Pathways and Targets in Melanoma: An Update about Immunotherapy, and Combination Strategies.This international congress gathered more than 30 international faculty members and was focused on recent advances in melanoma molecular biology, immunology and therapy, and created an interactive atmosphere which stimulated discussion of new approaches and strategies in the field of melanoma.

【 授权许可】

CC BY   
© Ascierto et al.; licensee BioMed Central Ltd. 2012